Bunazosin
Bunazosin is a medication primarily used to treat hypertension (high blood pressure) and benign prostatic hyperplasia (BPH). It belongs to the class of drugs known as alpha-1 adrenergic receptor antagonists, or alpha blockers.
Mechanism of Action[edit | edit source]
Bunazosin works by blocking the alpha-1 adrenergic receptors in the smooth muscle of blood vessels and the prostate. This action leads to the relaxation of these muscles, resulting in the dilation of blood vessels, which lowers blood pressure, and the easing of urinary symptoms associated with BPH.
Medical Uses[edit | edit source]
Hypertension[edit | edit source]
Bunazosin is used to manage hypertension by relaxing the blood vessels, allowing blood to flow more easily. This helps to lower blood pressure and reduce the risk of complications such as stroke, heart attack, and kidney failure.
Benign Prostatic Hyperplasia[edit | edit source]
In patients with benign prostatic hyperplasia, bunazosin helps to relieve symptoms such as difficulty in urination, weak stream, and the need to urinate frequently or urgently. By relaxing the muscles in the prostate and bladder neck, it improves urine flow and reduces the symptoms of BPH.
Side Effects[edit | edit source]
Common side effects of bunazosin include dizziness, headache, fatigue, and nausea. More serious side effects can include hypotension (abnormally low blood pressure), syncope (fainting), and tachycardia (rapid heart rate).
Contraindications[edit | edit source]
Bunazosin should not be used in patients with a known hypersensitivity to the drug or any of its components. Caution is advised in patients with a history of orthostatic hypotension, severe coronary artery disease, or liver impairment.
Pharmacokinetics[edit | edit source]
Bunazosin is well absorbed from the gastrointestinal tract and undergoes extensive first-pass metabolism in the liver. It has a half-life of approximately 16 hours, allowing for once-daily dosing in most patients.
History[edit | edit source]
Bunazosin was developed as part of the search for effective alpha-1 adrenergic receptor antagonists for the treatment of hypertension and BPH. It has been used in clinical practice for several years and is available in various countries under different brand names.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
-
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD